Altankov G, Smilenov L
Central Laboratory of Biophysics, Bulgarian Academy of Sciences, Sofia.
Haematologia (Budap). 1989;22(2):115-23.
The adhesive properties of human peripheral lymphocytes (HPL) towards immunobilized substrate in vitro have been investigated. The role of plasma fibronectin was studied in two different systems: a) immobilized fibronectin as a model of cell adhesion in the tissues; b) soluble fibronectin as a model for cell adhesion in blood circulation. Collagen (Type I) or collagen-fibronectin-coated surfaces were used as substrate for lymphocyte adhesion in system b. A very small amount of HPL (5.1 +/- 1.2%) was attached to the collagen surface. The adhesion to fibronectin or to collagen-fibronectin surfaces, however, was substantially higher, reaching a value of 34.1 +/- 3.8% and 32.7 +/- 5.8%, respectively. The addition of soluble fibronectin to system a leads to a competitive inhibition of adhesion. On the contrary, in the presence of soluble fibronectin, the augmentation of the lymphocyte adhesion to collagen was found to be dose-dependent and nearly 4 times higher as compared to the control level. This effect was found to be maximal at fibronectin concentrations of 250-300 micrograms/ml. The data demonstrate the important role of plasma fibronectin in the adhesive interactions of lymphocytes.
对人外周血淋巴细胞(HPL)在体外对免疫固定化底物的黏附特性进行了研究。在两种不同系统中研究了血浆纤连蛋白的作用:a)固定化纤连蛋白作为组织中细胞黏附的模型;b)可溶性纤连蛋白作为血液循环中细胞黏附的模型。在系统b中,使用胶原蛋白(I型)或胶原蛋白-纤连蛋白包被的表面作为淋巴细胞黏附的底物。极少量的HPL(5.1±1.2%)附着在胶原蛋白表面。然而,对纤连蛋白或胶原蛋白-纤连蛋白表面的黏附则显著更高,分别达到34.1±3.8%和32.7±5.8%的值。向系统a中添加可溶性纤连蛋白会导致黏附的竞争性抑制。相反,在可溶性纤连蛋白存在的情况下,发现淋巴细胞对胶原蛋白的黏附增强呈剂量依赖性,并且比对照水平高近4倍。在纤连蛋白浓度为250 - 300微克/毫升时,这种效应最大。数据表明血浆纤连蛋白在淋巴细胞的黏附相互作用中起重要作用。